{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:38:45Z","timestamp":1792622325920,"version":"4.5.0"},"reference-count":15,"publisher":"MyJove Corporation","issue":"168","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/62094","type":"journal-article","created":{"date-parts":[[2021,2,28]],"date-time":"2021-02-28T19:00:07Z","timestamp":1614538807000},"source":"Crossref","is-referenced-by-count":1,"title":["Positron Emission Tomography Imaging for <em>In Vivo<\/em> Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis"],"prefix":"10.3791","author":[{"given":"Daniele","family":"de Paula Faria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline Cristiano","family":"Real","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa","family":"Estessi de Souza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Teles Garcez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio Luis","family":"Navarro Marques","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Alberto","family":"Buchpiguel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2021,2,28]]},"reference":[{"issue":"6","key":"ref1","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1097\/WCO.0000000000000622","type":"journal-article","article-title":"Multiple sclerosis: clinical aspects","volume":"31","author":"Oh","year":"2018","unstructured":"Oh, J., Vidal-Jordana, A., Montalban, X. Multiple sclerosis: clinical aspects. Current Opinion in Neurology. 31 (6), 752-759, (2018).","journal-title":"Current Opinion in Neurology"},{"issue":"3","key":"ref2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/WCO.0000000000000206","type":"journal-article","article-title":"Classification, diagnosis, and differential diagnosis of multiple sclerosis","volume":"28","author":"Sand","year":"2015","unstructured":"Sand, I. K. Classification, diagnosis, and differential diagnosis of multiple sclerosis. Current Opinion in Neurology. 28 (3), 193-205, (2015).","journal-title":"Current Opinion in Neurology"},{"issue":"2","key":"ref3","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","type":"journal-article","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","unstructured":"Thompson, A. J. et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurology. 17 (2), 162-173, (2018).","journal-title":"Lancet Neurology"},{"issue":"11","key":"ref4","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1038\/jcbfm.2015.120","type":"journal-article","article-title":"Quantification of C-11 PIB PET for imaging myelin in the human brain: a test-retest reproducibility study in high-resolution research tomography","volume":"35","author":"Veronese","year":"2015","unstructured":"Veronese, M. et al. Quantification of C-11 PIB PET for imaging myelin in the human brain: a test-retest reproducibility study in high-resolution research tomography. Journal of Cerebral Blood Flow and Metabolism. 35 (11), 1771-1782, (2015).","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.msard.2019.07.020","type":"journal-article","article-title":"C-11 PIB PET imaging can detect white and grey matter demyelination in a non-human primate model of progressive multiple sclerosis","volume":"35","author":"Carvalho","year":"2019","unstructured":"Carvalho, R. H. F. et al. C-11 PIB PET imaging can detect white and grey matter demyelination in a non-human primate model of progressive multiple sclerosis. Multiple Sclerosis and Related Disorders. 35, 108-115, (2019).","journal-title":"Multiple Sclerosis and Related Disorders"},{"issue":"4","key":"ref6","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/ana.22320","type":"journal-article","article-title":"Imaging central nervous system myelin by positron emission tomography in multiple sclerosis using [methyl-(1)(1)C]-2-(4'-methylaminophenyl)- 6-hydroxybenzothiazole","volume":"69","author":"Stankoff","year":"2011","unstructured":"Stankoff, B. et al. Imaging central nervous system myelin by positron emission tomography in multiple sclerosis using [methyl-(1)(1)C]-2-(4'-methylaminophenyl)- 6-hydroxybenzothiazole. Annals of Neurology. 69 (4), 673-680, (2011).","journal-title":"Annals of Neurology"},{"issue":"10","key":"ref7","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.4103\/1673-5374.280311","type":"journal-article","article-title":"Myelin positron emission tomography (PET) imaging in multiple sclerosis","volume":"15","author":"Faria","year":"2020","unstructured":"Faria, D. D. Myelin positron emission tomography (PET) imaging in multiple sclerosis. Neural Regeneration Research. 15 (10), 1842-1843, (2020).","journal-title":"Neural Regeneration Research"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s00259-018-4182-1","type":"journal-article","article-title":"Amyloid PET as a marker of normal-appearing white matter early damage in multiple sclerosis: correlation with CSF -amyloid levels and brain volumes","volume":"46","author":"Pietroboni","year":"2019","unstructured":"Pietroboni, A. M. et al. Amyloid PET as a marker of normal-appearing white matter early damage in multiple sclerosis: correlation with CSF -amyloid levels and brain volumes. European Journal of Nuclear Medicine and Molecular Imaging. 46 (2), 280-287, (2019).","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"key":"ref9","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.101926","type":"journal-article","article-title":"Amyloid PET findings in multiple sclerosis are associated with cognitive decline at 18 months","volume":"39","author":"Pytel","year":"2020","unstructured":"Pytel, V. et al. Amyloid PET findings in multiple sclerosis are associated with cognitive decline at 18 months. Multiple Sclerosis and Related Disorders. 39, (2020).","journal-title":"Multiple Sclerosis and Related Disorders"},{"issue":"11","key":"ref10","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1177\/1352458514526941","type":"journal-article","article-title":"PET imaging of glucose metabolism, neuroinflammation and demyelination in the lysolecithin rat model for multiple sclerosis","volume":"20","author":"Faria","year":"2014","unstructured":"Faria, D. d. P. et al. PET imaging of glucose metabolism, neuroinflammation and demyelination in the lysolecithin rat model for multiple sclerosis. Multiple Sclerosis Journal. 20 (11), 1443-1452, (2014).","journal-title":"Multiple Sclerosis Journal"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.nbd.2016.09.003","type":"journal-article","article-title":"Galectin-1 circumvents lysolecithin-induced demyelination through the modulation of microglial polarization\/phagocytosis and oligodendroglial differentiation","volume":"96","author":"Rinaldi","year":"2016","unstructured":"Rinaldi, M. et al. Galectin-1 circumvents lysolecithin-induced demyelination through the modulation of microglial polarization\/phagocytosis and oligodendroglial differentiation. Neurobiology of Disease. 96, 127-143, (2016).","journal-title":"Neurobiology of Disease"},{"issue":"5","key":"ref12","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s00259-013-2682-6","type":"journal-article","article-title":"PET imaging of focal demyelination and remyelination in a rat model of multiple sclerosis comparison of [C-11]MeDAS, [C-11]CIC and [C-11]PIB","volume":"41","author":"Faria","year":"2014","unstructured":"Faria, D. d. P. et al. PET imaging of focal demyelination and remyelination in a rat model of multiple sclerosis: comparison of [C-11]MeDAS, [C-11]CIC and [C-11]PIB. European Journal of Nuclear Medicine and Molecular Imaging. 41 (5), 995-1003, (2014).","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"issue":"5","key":"ref13","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s00259-013-2682-6","type":"journal-article","article-title":"PET imaging of focal demyelination and remyelination in a rat model of multiple sclerosis: comparison of [11C]MeDAS, [11C]CIC and [11C]PIB","volume":"41","author":"Faria","year":"2014","unstructured":"Faria Dde, P. et al. PET imaging of focal demyelination and remyelination in a rat model of multiple sclerosis: comparison of [11C]MeDAS, [11C]CIC and [11C]PIB. European Journal of Nuclear Medicine and Molecular Imaging. 41 (5), 995-1003, (2014).","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"issue":"5","key":"ref14","doi-asserted-by":"crossref","first-page":"570","DOI":"10.2174\/187152712801661284","type":"journal-article","article-title":"In Vitro and In Vivo Models of Multiple Sclerosis","volume":"11","author":"vander Star","year":"2012","unstructured":"van der Star, B. J. et al. In Vitro and In Vivo Models of Multiple Sclerosis. CNS & Neurological Disorders-Drug Targets. 11 (5), 570-588, (2012).","journal-title":"CNS & Neurological Disorders-Drug Targets"},{"issue":"7555","key":"ref15","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nature14335","type":"journal-article","article-title":"Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo","volume":"522","author":"Najm","year":"2015","unstructured":"Najm, F. J. et al. Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo. Nature. 522 (7555), 216, (2015).","journal-title":"Nature"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jove.com\/t\/62094\/positron-emission-tomography-imaging-for-vivo-measuring-myelin","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T21:57:43Z","timestamp":1792619863000},"score":1,"resource":{"primary":{"URL":"https:\/\/app.jove.com\/t\/62094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,28]]},"references-count":15,"journal-issue":{"issue":"168","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.3791\/62094","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,28]]}}}